NO20061246L - Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse - Google Patents

Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse

Info

Publication number: NO20061246L
Authority: NO; Norway
Prior art keywords: salts; pyrrole; polymorphic forms; indolinone compound; substituted indolinone
Prior art date: 2003-10-02

Application number

NO20061246A

Other languages

English (en)

Norwegian (no)

Inventor

Andrei Blasko

Qingwu Jin

Qun Lu

Michael Anthony Mauragis

Dian Song

Brenda Sue Vonderwell

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-02

Filing date

2006-03-17

Publication date

2006-03-29

2006-03-17 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2006-03-29 Publication of NO20061246L publication Critical patent/NO20061246L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

NO20061246A 2003-10-02 2006-03-17 Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse NO20061246L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US50810403P	2003-10-02	2003-10-02
PCT/IB2004/003070 WO2005033098A1 (en)	2003-10-02	2004-09-20	Salts and polymorphs of a pyrrole-substituted indolinone compound

Publications (1)

Publication Number	Publication Date
NO20061246L true NO20061246L (no)	2006-03-29

Family

ID=34421700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061246A NO20061246L (no)	2003-10-02	2006-03-17	Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse

Country Status (26)

Country	Link
US (1)	US7247627B2 (ja)
EP (1)	EP1670785B1 (ja)
JP (1)	JP4933259B2 (ja)
KR (2)	KR20080007520A (ja)
CN (1)	CN100432072C (ja)
AR (1)	AR047762A1 (ja)
AT (1)	ATE473223T1 (ja)
AU (1)	AU2004277464B2 (ja)
BR (1)	BRPI0415022A (ja)
CA (1)	CA2540639C (ja)
CY (1)	CY1110771T1 (ja)
DE (1)	DE602004028028D1 (ja)
DK (1)	DK1670785T3 (ja)
ES (1)	ES2348623T3 (ja)
HK (1)	HK1093068A1 (ja)
IL (1)	IL174414A (ja)
MX (1)	MXPA06003661A (ja)
NO (1)	NO20061246L (ja)
NZ (1)	NZ546001A (ja)
PL (1)	PL1670785T3 (ja)
PT (1)	PT1670785E (ja)
RU (1)	RU2319702C2 (ja)
SI (1)	SI1670785T1 (ja)
TW (1)	TW200524921A (ja)
WO (1)	WO2005033098A1 (ja)
ZA (1)	ZA200602691B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050182122A1 (en) *	2003-11-20	2005-08-18	Bello Carlo L.	Method of treating abnormal cell growth using indolinone compounds
NZ561138A (en) *	2005-03-23	2009-06-26	Pfizer Prod Inc	Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer
CN101267824A (zh) *	2005-09-20	2008-09-17	辉瑞产品公司	使用酪氨酸激酶抑制剂的治疗剂型和方法
TWI384986B (zh) *	2007-01-17	2013-02-11	Lg Life Sciences Ltd	抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
KR101428833B1 (ko) *	2007-04-04	2014-08-08	오츠카 가가쿠 가부시키가이샤	티탄산칼륨, 그의 제조 방법, 마찰재 및 수지 조성물
MY151100A (en) *	2008-09-17	2014-04-15	Novartis Ag	Salts of n-[6-cis-2, 6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4?-(trifluoromethoxy)[1,1?-biphenyl]-3-carboxamide
WO2012042421A1 (en)	2010-09-29	2012-04-05	Pfizer Inc.	Method of treating abnormal cell growth
US9851313B2 (en) *	2015-03-03	2017-12-26	Panalytical B.V.	Quantitative X-ray analysis—ratio correction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5534522A (en) *	1995-06-07	1996-07-09	Warner-Lambert Company	(R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
DE19622489A1 (de) *	1996-06-05	1997-12-11	Hoechst Ag	Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
PE20011083A1 (es)	2000-02-15	2001-10-26	Sugen Inc	2-indolinas sustituidas con pirroles inhibidoras de proteinquinasas
AR042586A1 (es) *	2001-02-15	2005-06-29	Sugen Inc	3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
DK1419151T3 (da)	2001-08-15	2014-03-31	Pharmacia & Upjohn Co Llc	Krystaller indeholdende et malatsyresalt af N-[2-(diethylamino)ethyl]-5-[(5-fluor-1,2-dihydro-2-oxo-3H-indol-3-yliden)methyl]-2,4-dimethyl-1H-pyrrol-3-carboxyamid, fremgangsmåder til fremstilling deraf og sammensætninger deraf
YU67702A (sh)	2001-09-28	2004-12-31	Pfizer Products Inc.	Postupak za dobijanje alkansulfonil piridina
TWI259081B (en) *	2001-10-26	2006-08-01	Sugen Inc	Treatment of acute myeloid leukemia with indolinone compounds
EP1476443A2 (en) *	2002-02-15	2004-11-17	PHARMACIA & UPJOHN COMPANY	Process for preparing indolinone derivatives
TW200418836A (en) *	2002-09-10	2004-10-01	Pharmacia Italia Spa	Formulations comprising an indolinone compound

2004
- 2004-09-20 KR KR1020087000428A patent/KR20080007520A/ko not_active Application Discontinuation
- 2004-09-20 ES ES04769435T patent/ES2348623T3/es not_active Expired - Lifetime
- 2004-09-20 WO PCT/IB2004/003070 patent/WO2005033098A1/en active Application Filing
- 2004-09-20 AT AT04769435T patent/ATE473223T1/de active
- 2004-09-20 RU RU2006110541/04A patent/RU2319702C2/ru not_active IP Right Cessation
- 2004-09-20 NZ NZ546001A patent/NZ546001A/en unknown
- 2004-09-20 KR KR1020067006363A patent/KR20060058728A/ko active Search and Examination
- 2004-09-20 JP JP2006530728A patent/JP4933259B2/ja not_active Expired - Fee Related
- 2004-09-20 EP EP04769435A patent/EP1670785B1/en not_active Expired - Lifetime
- 2004-09-20 PL PL04769435T patent/PL1670785T3/pl unknown
- 2004-09-20 PT PT04769435T patent/PT1670785E/pt unknown
- 2004-09-20 BR BRPI0415022-8A patent/BRPI0415022A/pt not_active IP Right Cessation
- 2004-09-20 CN CNB2004800287364A patent/CN100432072C/zh not_active Expired - Fee Related
- 2004-09-20 AU AU2004277464A patent/AU2004277464B2/en not_active Ceased
- 2004-09-20 DK DK04769435.1T patent/DK1670785T3/da active
- 2004-09-20 SI SI200431486T patent/SI1670785T1/sl unknown
- 2004-09-20 CA CA2540639A patent/CA2540639C/en not_active Expired - Fee Related
- 2004-09-20 MX MXPA06003661A patent/MXPA06003661A/es active IP Right Grant
- 2004-09-20 DE DE602004028028T patent/DE602004028028D1/de not_active Expired - Lifetime
- 2004-09-30 US US10/956,420 patent/US7247627B2/en not_active Expired - Fee Related
- 2004-10-01 AR ARP040103580A patent/AR047762A1/es not_active Application Discontinuation
- 2004-10-01 TW TW093129924A patent/TW200524921A/zh unknown
2006
- 2006-03-17 NO NO20061246A patent/NO20061246L/no not_active Application Discontinuation
- 2006-03-20 IL IL174414A patent/IL174414A/en not_active IP Right Cessation
- 2006-03-31 ZA ZA200602691A patent/ZA200602691B/en unknown
- 2006-12-15 HK HK06113815.0A patent/HK1093068A1/xx not_active IP Right Cessation
2010
- 2010-09-03 CY CY20101100810T patent/CY1110771T1/el unknown

Also Published As

Publication number	Publication date
DK1670785T3 (da)	2010-10-18
KR20060058728A (ko)	2006-05-30
IL174414A (en)	2011-12-29
EP1670785A1 (en)	2006-06-21
DE602004028028D1 (de)	2010-08-19
PT1670785E (pt)	2010-09-16
WO2005033098A8 (en)	2006-04-20
CA2540639C (en)	2010-08-31
CN1863796A (zh)	2006-11-15
PL1670785T3 (pl)	2010-12-31
CY1110771T1 (el)	2015-06-10
AU2004277464B2 (en)	2010-07-08
US20050118255A1 (en)	2005-06-02
WO2005033098A9 (en)	2006-05-26
WO2005033098A1 (en)	2005-04-14
SI1670785T1 (sl)	2010-10-29
RU2319702C2 (ru)	2008-03-20
JP4933259B2 (ja)	2012-05-16
CN100432072C (zh)	2008-11-12
BRPI0415022A (pt)	2006-11-28
MXPA06003661A (es)	2006-06-05
TW200524921A (en)	2005-08-01
CA2540639A1 (en)	2005-04-14
JP2007507482A (ja)	2007-03-29
HK1093068A1 (en)	2007-02-23
ZA200602691B (en)	2007-06-27
US7247627B2 (en)	2007-07-24
IL174414A0 (en)	2008-02-09
ES2348623T3 (es)	2010-12-09
EP1670785B1 (en)	2010-07-07
AU2004277464A1 (en)	2005-04-14
KR20080007520A (ko)	2008-01-21
ATE473223T1 (de)	2010-07-15
NZ546001A (en)	2009-09-25
RU2006110541A (ru)	2006-08-27
AR047762A1 (es)	2006-02-22

Similar Documents

Publication	Publication Date	Title
NO20061246L (no)	2006-03-29	Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse
NO2010002I1 (no)	2010-03-08	toceranibfosfat(Z)-5-[(5-fluor-2-oksy-1,2-dihydro-3H-indol-3-yliden)metyl]-2,4-dimetyl-N-(2-pyrrolidin-1-yletyl)-1H-pyrrol-3-karboksamid Dekkes som forbindelse av kravene 1,2,4,8 og 9 i patentet
NO20071290L (no)	2007-05-29	Enantiomert rene aminoheteroarylforbindelser som protein kinase inhibitorer
GB2431927A9 (en)	2009-02-25	1,2-Disubstituted indoles & derivatives thereof astherapeutic 5-iipoxygenase-activating protein (fl ap) inhibitors
UA107175C2 (uk)	2014-12-10	Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти
RS54607B1 (en)	2016-08-31	5-SUBSTITUATED HINAZOLINONE DERIVATIVES AS ANTI-CANCER AGENTS
NO20083918L (no)	2008-11-12	Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
EA200801381A1 (ru)	2009-02-27	Производные пиримидина
NO20082445L (no)	2008-09-03	Neuropeptid-2 reseptor-agonister
NO20071619L (no)	2007-04-25	Fremgangsmate for fremstilling av indazol forbindelse
PL368317A1 (en)	2005-03-21	Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
NO20082338L (no)	2008-06-25	Pyrimidinderivater for behandling av avvikende cellevekst
PE20080362A1 (es)	2008-04-25	Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
DE60328028D1 (de)	2009-07-30	Imidazolverbindungen als inhibitoren des transformierenden wachstumsfaktors (twf)
EP1554237A4 (en)	2006-11-02	PROCESS FOR SYNTHESIS OF ACYLOXYALKYL DERIVATIVES OF GABA ANALOGS
EA200970041A1 (ru)	2009-06-30	Ингибиторы акт (протеинкиназы в)
EA200970604A1 (ru)	2009-10-30	Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона
EP1628974A4 (en)	2008-05-07	HYDANTOIN DERIVATIVES AS INHIBITORS OF THE TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME (TACE)
AR049681A1 (es)	2006-08-30	Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
PT1713801E (pt)	2008-02-11	Processo para a preparação de 1-(2s,3s)-2-benzidril-n-(5- -terc-butil-2-metoxibenzil)-quinuclidina-3-amina
EA200600898A1 (ru)	2006-10-27	Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
NO20054071L (no)	2005-10-13	Polymorfer av pyrrol substituerte 2-indolinon protein kinase inhibitorer.
HU0600347D0 (en)	2006-06-28	Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon)
MXPA04003085A (es)	2004-09-06	Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
ITFI20040057A1 (it)	2004-06-10	Analoghi della somatostatina

Legal Events

Date	Code	Title	Description
2009-04-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application